Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT1A | P50416 | 17/20 | 1.00 |
| ▸ | CPT1B | Q92523 | 17/20 | 1.00 |
| ▸ | CPT2 | P23786 | 14/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3578739 | 1.00 | CPT1A (1.00) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL30015360 | 0.94 | CPT1A (0.90) | CPT1ACPT1BCPT2MAPT | |
| SCHEMBL3582331 | 0.94 | CPT1A (0.90) | CPT1ACPT1BCPT2MAPT | |
| SCHEMBL3579234 | 0.92 | CPT1A (0.85) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL30015320 | 0.92 | CPT1A (0.85) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL3571461 | 0.90 | CPT1A (0.82) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL3571679 | 0.90 | CPT1A (0.85) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL30015215 | 0.90 | CPT1A (0.85) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL3577299 | 0.89 | CPT1A (0.80) | CPT1ACPT1BCPT2MAPTTP53 | |
| SCHEMBL30016529 | 0.89 | CPT1A (0.80) | CPT1ACPT1BCPT2MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022212568-A9 | COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM | 1BASE PHARMACEUTICALS, LLC (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2022212568-A1 | COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM | 1BASE PHARMACEUTICALS, LLC (US) | 2022-10-06 | — | — | WO | disclosed |